Categories: OLD Media Moves

NYTimes, USA Today and two North Carolina papers win Barlett & Steele Awards

The New York Times, USA Today and a joint project by The Charlotte Observer and The (Raleigh) News & Observer won gold, silver and bronze awards respectively in the sixth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced Thursday.

Named for the renowned investigative team of Don Barlett and Jim Steele, whose numerous awards include two Pulitzer Prizes, these annual awards funded by the Reynolds Center celebrate the best in investigative business journalism.

GOLD: “Vast Mexico Bribery Case Hushed Up by Wal-Mart after Top-Level Struggle,” by David Barstow of The New York Times, received the top gold award of $5,000. Barstow obtained hundreds of confidential documents and interviewed important players in the company’s internal inquiry. He discovered Wal-Mart had received powerful evidence that its Mexican executives used systematic bribery payments totaling more than $24 million to obtain zoning rulings and construction permits.

SILVER: “Ghost Factories,” by lead reporters Alison Young and Peter Eisler of USA Today, received the silver award of $2,000. The series involved a 14-month investigation that revealed locations of more than 230 long-forgotten smelters and the poisonous lead they left behind. Reporters used handheld X-ray devices to collect and test 1,000 soil samples to prove there was a serious threat to children living in dozens of neighborhoods.

BRONZE: “Prognosis: Profits,” by Ames Alexander, Karen Garloch, Joseph Neff and David Raynor, received the $1,000 bronze award for a joint project of The Charlotte Observer and The (Raleigh) News & Observer. Reporters dissected finances of large institutions through documents and sources to paint a compelling picture of nonprofit hospitals that function as for-profit institutions—often to the detriment of their care and charity missions. Discovered were inflated prices on drugs and procedures, lawsuits against thousands of needy patients and minimal charity care to poor and uninsured patients.